2027 Leads Prescription 
World of DTC Marketing
JULY 28, 2022
Nationwide, prescription drug spending last year is estimated to be $328 billion among all payers, including private insurance, Medicare Part D, and patients’ out-of-pocket expenses. Nearly 9 in 10 older adults take prescription medication. Still, the pharma industry is fighting hard to keep it off the table.
World of DTC Marketing
APRIL 12, 2022
High healthcare prices can limit patients’ ability to take what physicians prescribe, which leads to worse health outcomes, larger medical bills, and often financial hardship for patients, including bankruptcy. It also raises healthcare costs for public and private insurers alike. That’s about $375 per month.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
SEPTEMBER 21, 2023
As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry. CMS negotiation may lead to additional savings for beneficiaries and for the Medicare program.
LEVO Health
JULY 15, 2024
billion by 2027. Given their effectiveness, GLP-1 medications have gained popularity, leading to a surge in market demand. Key benefits of partnering with WellSync include: Fast Start-up Times: Quick deployment of your GLP-1 prescription program to meet patient demand swiftly. In 2021, the GLP-1 market was valued at $16.53
Clarivate
OCTOBER 25, 2023
While more expensive than type 2 diabetes drugs, blood thinners follow a similar pattern of high prescription volumes. The dearth of cancer drugs (only blood cancer drug Imbruvica made this first list) stems from CMS only pursuing negotiations for Part D drugs in 2026 and 2027, then expanding to Part B drugs in 2028. With 27.5%
PM360
JUNE 29, 2022
Prescription refills can now be placed with a simple click on a patient portal. markets by 2025 and 1,000 by 2027—and more than half of those practices are expected to be in medically underserved communities. The companies that can gain trust and deliver value have a chance to lead the pack.
PM360
SEPTEMBER 21, 2023
As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. Figure 1: Share of net spending for specialty and traditional prescription medications. The Uses—and Costs—of Specialty Treatments Keep Rising A U.S.
Expert insights. Personalized for you.
256 
Let's personalize your content